The aim of the study was to evaluate the urodynamic findings in women who smoke cigarettes, with bothersome lower urinary tract symptoms, to help develop an understanding of potential impact of smoking on the lower urinary tract function. Methods: A database of 11,678 women who underwent urodynamic testing in a tertiary referral centre in the United Kingdom, from January 1991 to December 2009 was retrospectively analysed. All women reporting cigarette smoking were included in the study group. Urodynamic testing and interpretation of results were done in accordance with the recommendations of the International Continence Society. Results: Overall, 2,476 (21.2%) women reported smoking cigarettes. Overactive bladder symptoms (OAB) were more common in smokers (OR 1.14, p = 0.006). Female smokers significantly complained of secondary nocturnal enuresis (OR 2.26, p < 0.001) and coital incontinence (CI; OR 1.14, p < 0.001). Detrusor overactivity (DO; OR 1.42, p < 0.001) and detrusor overactivity incontinence (DOI; OR 1.42, p < 0.001) were the most significant urodynamic findings. Smoking was not shown to be significantly associated with SUI (OR 1.08, p = 0.213) or urodynamic stress incontinence (OR 0.86, p = 0.001). Conclusion: Cigarette smoking is associated with OAB, secondary nocturnal enuresis and CI. DO and DOI are the most significant urodynamic findings.

Keywords:
Cigarette smoking, Urodynamics, Stress urinary incontinence, Detrusor overactivity, Detrusor overactivity incontinence, Adult onset nocturnal enuresis
1.
Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF: Systemic effects of smoking. Chest 2007;131:1557-1566.
2.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2224-2260.
3.
Lemmens V, Oenema A, Knut IK, Brug J: Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 2008;17:535-544.
4.
Zeegers MP, Kellen E, Buntinx F, van den Brandt PA: The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21:392-401.
5.
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL: Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-506.
6.
Bump RC, McClish DK: Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol 1992;167:1213-1218.
7.
Danforth KN, Townsend MK, Lifford K, Curhan GC, Resnick NM, Grodstein F: Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 2006;194:339-345.
8.
Dallosso HM, McGrother CW, Matthews RJ, Donaldson MM: The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003;92:69-77.
9.
Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S: Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT study. BJOG 2003;110:247-254.
10.
Burgio KL, Matthews KA, Engel BT: Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol 1991;146:1255-1259.
11.
Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D: Urinary incontinence in older women: who is at risk? Study of osteoporotic fractures research group. Obstet Gynecol 1996;87(5 pt 1):715-721.
12.
Roe B, Doll H: Lifestyle factors and continence status: comparison of self-report data from a postal survey in England. J Wound Ostomy Continence Nurs 1999;26:312-313, 315-319.
13.
Bump RC, McClish DM: Cigarette smoking and pure genuine stress incontinence of urine: a comparison of risk factors and determinants between smokers and nonsmokers. Am J Obstet Gynecol 1994;170:579-582.
14.
Tampakoudis P, Tantanassis T, Grimbizis G, Papaletsos M, Mantalenakis S: Cigarette smoking and urinary incontinence in women - a new calculative method of estimating the exposure to smoke. Eur J Obstet Gynecol Reprod Biol 1995;63:27-30.
15.
Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al: Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261-274.
16.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al: The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn 2002;21:167-178.
17.
Milsom I: Lower urinary tract symptoms in women. Curr Opin Urol 2009;19:337-341.
18.
Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S: Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT study. BJOG 2003;110:247-254.
19.
Masuda H, Hayashi Y, Chancellor MB, Kihara K, de Groat WC, de Miguel F, et al: Roles of peripheral and central nicotinic receptors in the micturition reflex in rats. J Urol 2006;176:374-379.
20.
Bump RC, McClish DK: Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol 1992;167:1213-1218.
21.
Integrated Household Survey: Integrated Household Survey (Internet). 2014. http://www.ons.gov.uk/ons/rel/integrated-household-survey/integrated-household-survey/January-to-December-2013/index.html (cited February 26, 2015).
22.
Wadie BS: Primary nocturnal enuresis persistent to adulthood, functional evaluation. Neurourol Urodyn 2004;23:54-57.
23.
Mendelsohn C: Smoking and depression - a review. Aust Fam Physician 2012;41:304-307.
24.
Paperwalla KN, Levin TT, Weiner J, Saravay SM: Smoking and depression. Med Clin North Am 2004;88:1483-1494, x-xi.
25.
Quattrocki E, Baird A, Yurgelun-Todd D: Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 2000;8:99-110.
26.
Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014;1:CD000031.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.